Chongqing Genrix Biopharmaceutical Co., Ltd
1 clinical trials · Sponsor
◉ Watch Chongqing Genrix Biopharmaceutical Co., Ltd
| Record | Firm | Date |
|---|---|---|
| Real-World Study of Xeligekimab for Moderate to Severe Plaque Psoriasis(XP-Real) (NCT06802848) | Chongqing Genrix Biopharmaceutical Co., Ltd | 2025-01-30 |
Track Chongqing Genrix Biopharmaceutical Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.